NKGN NKGEN BIOTECH INC COM STK (DE)
FollowEquity (common)
3 managers (3 13F filers) reported a position in NKGN shares at 2025-03-31, 892,354 shares in all. 1 filer opened a position and 24 filers sold out during the quarter.
- Managers
- 3
- 13F filers
- 3
- New
- 1
- Added
- 0
- Reduced
- 1
- Sold out
- 24
- Shares held by filers
- 892,354
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q1 2025
Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Diametric Capital, LP | 518,134 | $93.3K | 0.11% | 0 | 13F-HRTimeline |
| UNIVERSITY OF CHICAGO | 325,000 | $58.5K | 0.09% | -225,000 | 13F-HRTimeline |
| FLOW TRADERS U.S. LLC | 49,220 | $9K | <0.01% | new | 13F-HRTimeline |